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1. Introduction 
With increasing knowledge about the cardiovascular diseases and with more advanced 
technology, indications for implantation of pacemakers are expanding. By the end of 2007, 
about 560,000 pacemakers were implanted in North America and 680,000 in Europe. With 
the increasing prevalence of pacemakers, management and follow up of these complex 
patients is becoming an ongoing issue. Close monitoring and interrogation of their 
pacemakers remains a main part of the complete evaluation of these patients. It is estimated 
that in North America and in Europe, there are 3.2 million pacemaker encounters per year. 
Due to huge number of patients, following all the patients in the outpatient clinic/hospital 
on the regular basis may not be feasible. Hence, it has been suggested that telemonitoring 
system could provide a practical substitute to the time-consuming and expensive in-office 
visits.In this chapter, we will be describing the current technologies and also provide an 
update on this rapidly evolving topics, by incorporating the latest data and on-going trials.  
Telemonitoring is defined as the use of audiovisual and other information technologies to 
monitor patient status at a distance; it can be used in monitoring the cardiac and respiratory 
status of patients. In 1905, Einthoven transmitted Electro Cardio Gram (EKG) from a hospital 
to his home using a telephone line. In 1920s, Winters transmitted the heart sounds using a 
radio link. Later on in the 1960s, with increasing technological advances, the United States 
navy used the telemonitoring system to transmit their soldiers’ physiologic data from the ships 
to their shore hospital at Florida, USA (Institute of Medicine). In the past few decades, 
telemonitoring attained a robust development. Recent Heart Rhythm Society / European 
Heart Rhythm Association expert consensus on monitoring the cardiac devices (Wilkoff et al., 
2008) recommended that patients with pacemakers/defibrillators should be monitored at 
regular intervals based on the time elapsed after the device implantation. (Table 1) 
Telemonitoring may be subdivided into: 
1. Remote follow- up: 
Device data will be transferred from the patient to the physician’s office or to the central 
data processing center in a predetermined scheduled time using the wand / transmitter.  
2. Remote monitoring:  
In addition to the transmission of the data from the device on a daily basis, unscheduled 
transmission of the predefined alerts (e.g. battery depletion, improper sensing / capture), will 
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also happen. The data from the device will be transmitted and the physician will be notified, 
according to the predefined settings by the physician (e.g. information given to the 
physician/health care provider through SMS, emails, contacting the office through phone). 
 
Minimum frequency of monitoring of pacemakers either in person or remotely 
 Remote monitor In person follow - up 
Within 3 days of 
Implantation 
- X 
2-12 weeks post 
implantation 
- X 
Every 3-12 months after 
implantation 
X X 
Every 1-3 months at signs of 
battery depletion 
X X 
Annually until depletion of 
battery 
- X 
Table 1. Timeline for follow up of the Pacemakers 
X – Recommended; - Not recommended 
3. Bidirectional telemetry: 
In addition to the remote monitoring of the pacemakers, remote interrogation and remote 
programming of the pacemakers can be done with newer revolutionary technologies.  
2. Importance of monitoring the pacemaker: 
Monitoring of pacemakers is necessary for both patient- and device-related factors. Wilkoff 
et al. (2008) described the various important reasons and goals of monitoring pacemakers. 
By closely monitoring the pacemakers, the clinician would achieve the goals outlined below. 
(Table 2) 
 
Patient Centered Factors 
Optimize the patient’s quality of life 
Identify the patients at risk (based on the alerts) and appropriate follow up  
Identify any abnormal brady / tachy arrhythmias 
Identify non device related problems and appropriate referrals 
Patient safety 
Peace of mind for the patient 
 
Device Related Factors 
Optimize the pacemaker function to meet patients’ need 
Identify and correct abnormal device function 
Identify the end of life of the battery, monitor lead dysfunction 
Monitor the various alerts by the device and triage accordingly 
Maintain a database for future research purpose. 
Table 2. Factors effecting pacemaker placement 
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3. Description of the telemonitoring technology: 
Implanted pacemakers are pre-equipped with a micro-antenna, which communicates with a 
small external device, commonly known as transmitter. A receiver or “wand,” is attached by 
a wire to the programmer and positioned on the body’s surface over the pacemaker 
implantation site to receive the telemetry signal from the pacemaker. The wand will be 
talking to the device as radiofrequency signals {either the Industrial, Scientific and Medical 
(ISM) band from 902–928 MHz or a subsection of the Medical Implant and Communications 
(MICS) band from 402–405 MHz}. The distance for radiofrequency signal communication 
has increased from several cm to several meters and some devices can even communicate 
without a wand. The transmitters are able to interrogate programmed parameters and 
diagnostic data stored in the device memory with active participation of patient (via a 
wand), or automatically (wandless), at preset time intervals.  The data downloaded from the 
device by the transmitter is then uploaded as an encrypted data, to a secured clinical 
database either by a standard analog phone line or through wireless GSM (Global System 
for Mobile) connection. The programmer is a computer with specific software and 
associated hardware modifications that provide highly reliable exchange of the encrypted 
information and precise communication with the cardiac device. The transmission of these 
data may be initiated by patient (as a scheduled transmission or event triggered (symptom / 
alert by device).  
 
 
 
 
 
Fig. 1. Telemonitoring technology. 
The data will be processed in central processing center, which is usually maintained by the 
device manufacturers. The data will be uploaded in a secure website and a health care 
provider can login and look into the events (Figure 1). In addition to the uploading of the 
data to website, depending on clinical urgency, the concerned health care provider will be 
notified via email, SMS, fax or telephone call as predefined by the physicians. Moreover, 
some manufacturers follows a traffic light like system, in which the alerts will be sent to the 
clinician in varying colors like red, yellow and green, depending on the magnitude of the 
problem. Otherwise, after initiating manual transmission, patient also can call the physician, 
who can login to the password protected secure website and look into the events. 
Typically, the following informations are transmitted to database:  heart rate, battery status, 
lead integrity, pacing lead impedance, episodes of arrhythmias, delivered antitachycardia 
pacing, percent pacing, histogram, real-time and magnet Electrograms (EGM), stored EGMs 
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and arrhythmia summary with mode switch duration. These data will help the clinician to 
diagnose any active problems. In addition, monitoring of the silent events like 
asymptomatic atrial fibrillation is very important as these arrhythmias are proven to be an 
independent risk factor for increased mortality in patients with heart failure. In addition to 
these data, patient can also enter his blood pressure measurements, body weights and other 
symptoms related to heart failure (in patients with Cardiac Resynchronization Therapy 
{CRT}). Based on these data, physicians would be able to make changes in the management 
of the patient’s condition.  
Programmers can also communicate the interrogated data to a remote printer for a hard copy 
presentation or be transferred to a database or Electronic Medical Record (EMR). To connect to 
the database or to EMR, the data are saved and then transferred via disc, CD ROM, USB drive, 
directly by a network cable, Bluetooth or Wi-Fi communication to an internet or intranet 
network connection. The ISM and MICS radiofrequency communication is used only for 
connecting the pacemaker to the programmer or remote telemetry device and not for 
connecting the programmer to printers, saved files, the database, EMR or registries. 
4. Types of remote transmission: 
4.1 Patient initiated remote transmission: 
In this mode of transmission, the initiation of data transfer from the pacemaker is done by 
the patient himself / herself. This may be a regular, scheduled transmission or an 
unscheduled transmission, triggered either by the patient symptoms (like shortness of 
breath, lightheadedness, syncope, palpitations) or in response to an alert given by the 
pacemaker (usually an audible sound or vibration). 
4.2 Device initiated remote transmission: 
In this mode of transmission, initiation of data transfer from the pacemaker is done by the 
pacemaker itself. Data will be transferred on a regular scheduled basis, at fixed time 
intervals (often at night, when the patient is lying in bed). Usually, the patient need not 
place the wand over the pacemaker. The pacemaker itself will “talk” to the home monitor/ 
communicator and initiate transfer. If there is any change in patient’s physiologic data or 
any new alerts by the pacemakers, there will be an unscheduled initiation of the data 
transfer from the pacemaker, even without the knowledge of patient.  
4.3 Transtelephonic monitoring without interrogation: 
This is one of the older techniques. This technology is solely limited to pacemaker follow-
up. In this method of transmission, patient must initiate data transmission through a 
telephone. Each transmission usually includes an initial rhythm strip and then a rhythm 
strip demonstrating magnet rate of pacing system. Telephone transmissions provide only a 
brief snapshot of cardiac rhythm and thus intermittent problems may not be detected. It still 
has some value in monitoring the pacemakers approaching end of life and in need of 
elective replacement of the battery. 
5. Types of various tele monitors by 4 major companies: 
The following four types of remote monitors are produced by the various pacemaker 
manufacturers: 
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5.1 Biotronik 
In 2001, Biotronik introduced wireless remote monitoring of cardiac devices. Biotronik 
Home Monitoring uses three simple colours to quickly and automatically convey a wealth of 
vital information to physicians who need on-the-spot patient data anywhere, any time. 
When activated, Home Monitoring ® (Biotronik & Co. KG, Berlin, Germany) transmits data 
systematically on a daily basis, at a fixed time of day (usually in the night times), via a 
special cell phone-like instrument (CardioMessenger®, Biotronik Figure 2)) kept within 2 m 
from the implanted device. The transmission utilizes state-of-the-art encrypted SMS 
technology to transfer worldwide data to a dedicated center.  
 
 
Fig. 2. CardioMessenger® from Biotronik 
Event notifications are assigned by the physician with a red or yellow colour-code to ensure 
that only serious  or important  patient status changes are alerted to the physician. The 
"red-dot" principle serves as a simple navigator that lets physicians quickly assess the 
patient's status at a glance while allowing them to focus only on those cases with clinically 
relevant events. In addition to color-coded messages on the internet, the physician receives a 
notification via email, fax, or text message in case of serious changes in the patient’s status. 
Red              indicates a severe deviation from a defined threshold with high priority. 
 
Yellow         indicates an important deviation from a defined threshold with priority.  
 
White              indicates the absence of any severe or important change. 
 
When a clinically relevant status change occurs, Biotronik Home Monitoring® generates an 
event alert via email, SMS, or fax to the physician while simultaneously displaying the 
severity of the patients' status on the secure Biotronik Home Monitoring® website. It also 
offers information that might allow the detection of adverse events on average of 2 and 5 
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months earlier than feasible by standard care in patients followed quarterly and biannually, 
respectively (Ellery et al., 2006). The majority of the alerts are disease-related, prompted by 
atrial fibrillation, ventricular arrhythmias, and ICD or CRT therapy, in particular.  
5.2 CareLink® 
CareLink® is produced by Medtronic, Minneapolis, MN, USA.  The monitor produced by 
CareLink® is very small, about a pound in weight and easy to carry in a brief case. On the 
scheduled day, patients have to simply connect their monitor to a regular phone line, push 
the start button, and hold the antenna over heart device. The monitor sends the device 
information and turns itself off when the transmission is done. Data will be transferred to 
the secure central data collecting system; from there, the information will be passed on to 
the health care personnel as guided by the urgency of the information.  
If patients have a Medtronic heart device with Conexus Automatic Monitoring, the device 
data may be sent automatically, usually while the patient is sleeping. These transmissions 
are scheduled by the clinical team. On the scheduled night, the device “wakes up” and 
communicates with the monitor. The monitor silently sends the device data, without 
assistance from the patient. 
Heart devices with automatic monitoring are able to send a CareAlert® notification to the 
database, when certain conditions are met, such as low battery or an irregular heartbeat. 
This information will be appropriately transmitted to medical team (Figure 3).  
 
Fig. 3. CareAlert® 
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5.3 Latitude 
 
 
 
 
 
 
 
 
 
Fig. 4. Latitude Home Monitoring System 
Latitude system uses a wireless (e.g. radio frequency or Bluetooth®) feature that offers daily 
and/or weekly status checks with physician notification. This feature can be activated for 
patients who have a device that uses ZIP Wandless Telemetry, and/or for patients who use 
the weight scale from the Latitude Heart Failure Management system. 
There are two levels of alert conditions: red alerts and yellow alerts. The alerts are designed 
to provide the physician advance notification of a potential health or device problem.  
Conditions that could potentially leave the patient without available device therapy result in 
declaration of a red alert (Table 3). Notification of red alerts is not configurable, as the 
device-following physician will always be notified if a red alert is detected on the Latitude 
secure server. By default, notification is sent by telephone, but there are several notification 
options for red alerts as described in “Red Alert Notification Preferences.” 
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Daily Measurement Red Alerts 
• High or low shock lead impedance 
• High or low right ventricular pacing lead impedance 
Red Alerts Indicating Potential Loss of Therapy 
• Device battery has reached end of life (EOL) 
• Remote monitoring disabled due to limited battery capacity 
• High or low shock lead impedance detected when attempting to deliver a shock 
• High voltage detected on shock lead during charge 
• Ventricular tachycardia mode change due to magnet 
• Ventricular tachycardia mode set to value other than monitor + therapy 
• Possible malfunction 
• Device parameter error 
Table 3. Red alert notifications occur for the above conditions, depending on device model 
 
 
Device battery has reached Elective Replacement Indicator (ERI) 
Explant indicator reached 
Voltage was too low for projected remaining capacity 
Ventricular pacing leads 
• Low right ventricular intrinsic amplitude 
• High right ventricular intrinsic amplitude 
• Low left ventricular intrinsic amplitude 
• High left ventricular intrinsic amplitude 
• Low left ventricular pacing lead impedance 
• High left ventricular pacing lead impedance 
Atrial pacing leads 
• Low atrial intrinsic amplitude 
• High atrial intrinsic amplitude 
• Low atrial pacing lead impedance 
• High atrial pacing lead impedance 
Arrhythmias 
• Shock therapy delivered to convert arrhythmia (ventricular) 
• Accelerated arrhythmia episode (ventricular) 
• Atrial arrhythmia burden within a 24-hour period  
Patient triggered event stored 
Pacing 
• Cardiac resynchronization therapy pacing percentage  
• Right ventricular pacing percentage 
 An average daily weight change of 2 pounds or more over multiple days 
 Change of 5 pounds or more any time within a week 
Table 4. Yellow alert notifications occur for the above conditions, depending on device 
model and on the physicians’ preference 
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Notification of yellow alerts is optional by the physicians. Notification for yellow alerts is 
provided through the Latitude website and, optionally by other methods such as fax. A 
physician may choose to receive some, all, or none of the yellow alerts. Yellow alert 
notifications can be configured for the above conditions, depending on device model (Table 4). 
5.4 Merlin@Home®: 
 
 
Fig. 5. Merlin@ home Transmitter® 
In 2008, St Jude got FDA approval for Merlin@ home transmitter® (Figure 5), a radio 
frequency wireless technology that remotely monitors patients' implanted cardiac devices. 
The Merlin@ home transmitter's ®wireless technology gives patients the additional comfort 
of having devices automatically checked. Since the transmitter initiates scheduled follow-up 
and uses radio frequency wireless telemetry to download data from device, entire follow-up 
procedure is conducted without any direct patient involvement. The only requirement is 
that each patient remains within range of the transmitter while it reads his or her device. 
Patients also may initiate data transmissions as instructed by their physicians. Data 
downloaded by the Merlin@home transmitter® is sent to Merlin.net, a secure, internet-
based data management system, where it is stored for review by the patient's physician. The 
data can also be linked in to the Electronic Health Record / Electronic Medical Record 
directly and can be stored there for future references. 
Table comparing the 4 types of available remote monitors: 
Major differences among the available systems include degree of patient involvement in 
data transmission, transmission modality, transmission scheduling, and patient alerts as 
detailed in Table 5. 
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 Biotronik Medtronic 
Boston 
Scientific 
St Jude 
System Name 
Home 
MonitoringTM 
CareLinkTM LatitudeTM Merlin.netTM 
System 
Activation 
Automatic 
Automatic / 
Manual 
Automatic/ 
Manual 
Automatic / 
Manual 
Approved in 
America and 
Europe 
America and 
Europe 
America and 
Europe 
America and 
Europe 
Device to 
Programmer 
Wireless 
Wand / 
Wireless 
Wand / 
Wireless 
Wand / 
Wireless 
Programmer 
to Server 
4 – band GSM 
network (Cellular 
network) 
Analogue 
phone line 
Analogue 
phone line 
Analogue 
phone line 
Patient 
involvement 
No Yes Yes No 
Patient device 
characteristics 
Portable Stationary Stationary Stationary 
Frequency of 
transmissions 
Daily FU; Alert 
events 
Scheduled FU; 
Alert events 
Scheduled FU; 
Alert events 
Scheduled FU; 
Alert events 
Remote 
follow up 
Yes Yes Yes Yes 
Remote 
Monitor 
Yes Yes Yes Yes 
Data storage Website long term 
Website long 
term 
Website long 
term 
Website long 
term 
Data 
presentation 
Processed as 
graphs and tables 
Standard as in 
Programmer 
Standard as in 
Programmer 
Standard as in 
Programmer 
Real - time 
/stored EGM 
(duration) 
45 seconds 10 seconds 10 seconds 30 seconds 
Transmission 
time 
<0.5 minute <3 minutes 5 minutes < 3 minutes 
Feedback to 
the patient 
via 
transmitter 
LED indicating the 
status 
LED indicating 
the status 
Automatic text 
and audio 
messages 
LED indicating 
the status 
Special 
Features 
Wireless PMs 
Configurable 
red and yellow 
alerts 
Configurable 
red and yellow 
alerts 
Automated 
phone calls to 
patients 
Table 5. Comparison of the four different available remote monitors 
6. Benefits of telemonitor 
According to the Heart Rhythm Society Task Force on Device Performance Policies and 
Guidelines (Wilkoff et al., 2008), the primary goal of these remote, automated, wireless, or 
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internet- based cardiac rhythm device monitoring systems is to identify the abnormal device 
behavior in a more timely fashion, automatically and accurately determining the status of 
certain implanted device functions, thereby decreasing the reliance on reporting by the 
patients and physicians. However, in addition to the primary goal of earlier diagnosis, it 
does have other various advantages as described below.  
6.1 Reduction in clinic visits 
In a study by Brugada (2006), 271 patients with a Biotronik ICD and Home monitoring 
systems were routinely followed every three months over the course of a year. Retrospective 
analysis of the Biotronik Home Monitoring data showed that as many as half of the regular 
scheduled visits may have been skipped, without impairing patient safety. In addition to 
reducing the scheduled clinic visits, remote follow-up may avoid unscheduled visits 
following an ICD shock. After a shock / alert, the patient may perform manual transmission 
of the data to the physician for determining the appropriateness of the shock, and it may be 
then decided whether the patient should be seen for device reprogramming or modification 
of drug therapy. 
6.2 Early diagnosis of worsening clinical scenarios: 
Implantable cardiac devices can play a key role in the early detection and treatment of atrial 
fibrillation (AF) / atrial tachyarrhythmia (AT), which is an important marker of cardiac 
mortality. The possibility of early detection of AT/AF remains poor when relying on patient 
symptoms alone. Furthermore, reliance on patient symptoms alone may result in inappropriate 
medical therapy such as early discontinuation of anticoagulation. Intermittent monitoring via 
long-term event recorders or Holter monitors can be inadequate in documenting paroxysmal 
atrial tachyarrhythmias. Given the morbidity and mortality associated with AT/AF and the fact 
that AT/AF is often asymptomatic, early treatment and close monitoring may be helpful in 
reducing the risk of stroke and in monitoring treatment efficacy. 
These devices can accurately detect and continuously monitor for atrial tachyarrhythmias. The 
devices also have extensive reporting capabilities and can provide an objective picture of the 
cumulative length of time that a patient experiences atrial tachyarrhythmias.Hoppe et al. 
(2006) did a retrospective analysis of the Cardiac Resynchronization in Heart Failure (CARE-
HF) study involving 409 patients with CRT devices. They found that AF was documented 
without the aid of the device in 16.1% of the patients, while the device-based diagnostics 
detected AT/AF in an incremental 22% (93/409) of the patients during a mean follow-up of 
29.4 months. In a study of patients with AT/AF who also had an AT500R pacemaker 
(Medtronic, Inc., Minneapolis, MN) or a GEMR III ICD (Medtronic, Inc., Minneapolis, MN), 
Purerfellner et al. (2004) found that the devices had AT/AF episode detection accuracy of 
95.3% and 95.7%, respectively, and an AT/AF burden sensitivity of 95.3%. 
High ventricular rates in a patient with atrial arrhythmias are indicative of poor rate control. 
Poor rate control in itself can lead to the development of HF and can exacerbate existing HF. 
Additionally, poor rate control has been linked to earlier time to first hospitalization, HF 
exacerbation, and inappropriate ICD shocks, as noted by Hoppe et al (2006). In people with 
CRT devices, a fast ventricular response to AF can lead to a loss of biventricular pacing as the 
device mode switches to asynchronous pacing. Given that patients with HF can derive benefits 
from even small changes in hemodynamic status, the amount of biventricular pacing should 
be as close to 100% as possible in order to maximize patient benefit from the therapy. 
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Therefore, early identification of poor ventricular rate control allows for more rapid clinical 
interventions including changes in drug regimen or other treatment modalities (e.g., ablation) 
to optimize rate control with the goal of reducing hospitalizations and unnecessary shocks as 
well as helping to maximize the delivery of biventricular pacing in people with a CRT device.  
6.3 Improved patient satisfaction 
Most patients readily accept remote monitoring, and feel secured by the use of this 
technology to improve their healthcare. Studies have shown a high patient satisfaction rate, 
ease of use, and compliance with the use of remote monitoring systems (Joseph et al 2004). 
Patients feel reassured being consistently in contact with hospital. In an Italian multi center 
trial by Marzegalli et al (2008), with the CareLink® system,9 9% of patients rated the 
monitor setup as very or somewhat easy since their first transmission. About 98% of the 
patients found the antenna very easy or somewhat easy to position since the first 
transmission, and the time required for the procedure rated as brief or very brief in all after 
a short practice. Personal knowledge of the nurse who actually calls the patient in case of 
problems tremendously increases patient assurance and compliance. 
6.4 Cost saving 
The economic aspects have not been evaluated extensively. A study from France examined the 
potential cost savings for long-term care of ICD recipients assisted by Home Monitoring 
(www.theheart.org). A multicenter database for this study included 502 patients from six 
university hospitals. Costs of conventional ICD follow-up examinations were compared with 
the expected costs of follow-up coupled with telemonitoring. Assuming that telemonitoring 
may obviate up to 2 visits per year, the expected decrease in costs for follow-up visits was 
estimated at $2,149 per patient during the 5 years of expected service life of the device. 
Transportation expenses were the main component of the overall costs, and the savings due to 
telemonitoring were particularly significant when the distance between the patient home and 
the medical facility is longer. However, these results must be viewed with caution as this is 
looking only at expected, not actual costs and there is no robust data available at this time.  
6.5 Time saving 
As all the data gathered during a normal in-office device interrogation can be sent remotely 
to the device clinic for evaluation, the patients and accompanying persons save time by 
using the remote monitoring network. In a study conducted by Raatikainen et al. (2008), the 
average time saved was about 3 hours per patient per visit and it was directly related to the 
travelling distance to the device clinic. Also, the physicians on average save 20 minutes and 
other office staff saved 45 minutes for each visit, delivering the same care through the 
remote network. 
7. Drawbacks: 
7.1 Non compliance 
Some elderly people have difficulty when using transmission systems for which manual 
transmission is requested and need assistance from their relatives. A minority of patients do 
not accept remote monitoring. Reasons for that include concern about privacy, fear of 
technology, and concern about the risk of losing human contact with the nurses and 
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physicians. Some patients showed lower compliance post implantation, perhaps by 
forgetting to send transmissions or by switching off the transmitter. These are usually 
patients who did not accept their disease and device implantation. For them, psychological 
support and counseling are recommended. 
7.2 Patient safety due to technical problems: 
Transmission failures due to technical issues are rare. Infrequent transmission failures (2%) 
were observed due to mobile phone network defects or patients’ absence from home.Technical 
problems related to the mobile phone, e.g., battery depletion or a deactivated monitor were 
rarely reported. In a study of 93 patients, Wallbrück et al. (2002) assessed the feasibility of an 
automatic long-distance monitoring system for pacemaker patients, and the clinical relevance 
of transmitted data. Automatic daily transmission (mostly during the night) and patient 
triggered transmission were enabled. The number of received and sent messages was 
compared. To check data integrity, the transmitted data were compared with those collected 
by the pacemaker programmer. Three patients (3.2%) were excluded due to insufficient mobile 
net coverage at their living site. The authors showed that 89.7% of the messages automatically 
generated by the implanted devices and 64.8% of patient-triggered messages were received at 
the Home Monitoring Service Center. Various reasons could explain message failure: patient 
away from home at the time of transmission, monitor was switched off, device not correctly 
loaded, device too far away from the patient bed, or GSM network coverage unreliable. The 
interruption in the sequence of messages ranged from 1 to more than 4 days. In another study, 
Toselli et al. (2004) reported the data obtained from 894 scheduled reports, of which 876 (98%) 
were successful. When the investigators compared the Home Monitoring data with those 
retrieved during conventional ICD interrogation at the time of in-clinic follow-ups, they did 
not observe any difference. 
7.3 Patient confidentiality 
Data confidentiality is an issue of particular importance for the device company and for the 
physician. Since the data are now transmitted via internet in the vast majority of cases, the 
system is secured at each step of transmission – from the patient to the home monitoring 
service centre and from there to the physician. As with any advanced transmission technology, 
hacking is a potential issue. Hackers could transmit the same radio signals – causing a 
defibrillator to shock or shut down, or divulge a patient's medical information – without 
needing a programmer. It is widely believed that the risk of unauthorized access to an ICD is 
unlikely, given the considerable technical expertise required. (Wireless ICD programming 
vulnerable to hackers, report claims. http://www.theheart.org/ article/847781.do).  
7.4 Patient-physician relationship 
Joseph et al (2004) have shown a high patient satisfaction rate, ease of use, and compliance 
with the use of remote monitor. However, some patients may find difficulty in using the 
technology and they may feel that they lost the human contact with a health care provider. 
Proper explanation and psychological support to them holds the key.  
7.5 Legal issues 
As with any technology, patients should be informed about the advantages and 
disadvantages. Home Monitoring was developed to allow earlier detection of technical or 
www.intechopen.com
 Modern Pacemakers - Present and Future 
 
142 
arrhythmic events, but it does not protect the patient against such events nor does it allow 
any remote intervention by a physician. In case of an event, in addition to the use of the 
monitor, the patient must activate the Emergency Medical Services (EMS) as appropriate. 
Home monitoring devices are not a replacement for EMS.  A written informed consent form 
should be used to ensure that the patient has been properly informed about the system and 
that the patient agreed to use of it. 
8. Reimbursement: 
In the USA, on June 9, 2006, Centers for Medicare & Medicaid Services (CMS) published a 
transmittal stating that physicians should use (and carriers should pay for) existing Current 
Procedural Terminology codes 93731, 93734, 93741 and 93743 (the in-office pacemaker and 
ICD interrogation codes) for remote monitoring of cardiac devices.  Reimbursement rates 
vary from state to state, and in some instances are the same as an in-office visit without 
device programming. In Germany, the procedural reimbursement for remote monitoring is 
nearly the same as that offered for standard follow-up visits. Furthermore, there is currently 
no limit to the number of remote interrogations by physicians, who can either monitor the 
patient status at regular intervals (e.g., every 3 months), or in response to selected special 
events, or both. United Kingdom offers no reimbursement for remote monitoring. In France, 
the fees are fixed, and clinics and hospitals are reimbursed according to levels of activities. 
In Italy, the Italian Association on Arrhythmias and Cardiac Pacing is working with the 
National Public Health Service to develop reimbursement codes for remote monitoring. 
9. Ongoing trials in telemonitoring of the Cardiac devices 
Remote monitoring may be particularly useful in patients with cardiac resynchronization 
therapy, as they are most likely to have transmissions of medically related events. As 
detailed in table 6, a number of different randomized trials are currently underway to assess 
the utility of telemonitoring of pacemakers and defibrillators specifically looking for signs of 
volume overload, heart failure, shocks etc 
 
Study Title Condition Device Status 
CareLink® Evaluation 
Heart 
Failure 
Medtronic CareLink® 
Not yet 
recruiting 
Clinical Evaluation Of Remote 
Monitoring With Direct Alerts To 
Reduce Time From Event To 
Clinical Decision 
ICD / CRT Merlin.NET® Recruiting 
A Randomized Trial of Remote 
Monitoring of Implantable 
Cardioverter Defibrillators Versus 
Quarterly Device Interrogations in 
Clinic 
VT / VF 
CareLink®monitoring 
system 
Active, not 
recruiting 
Telemedical Interventional 
Monitoring in Heart Failure 
Heart 
Failure 
 
Active, not 
recruiting 
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European Health Economic Trial 
on Home Monitoring in ICD 
Therapy (EuroEco) 
VT / VF 
Home Monitoring 
provided by 
Biotronik ICD 
devices 
Recruiting 
MOnitoring REsynchronization 
deviCes and cARdiac patiEnts 
(MORE CARE) 
Heart 
Failure 
Medtronic CareLink® Recruiting 
Benefits of Implantable 
Cardioverter Defibrillator Follow-
up Using Remote Monitoring 
VT / VF /  
Heart 
Failure 
Home Monitor ® 
Active, not 
recruiting 
Home-Monitoring in Implantable 
Cardioverter Defibrillator (ICD) 
Patients 
VT / VF 
Home-monitoring 
provided by LUMAX 
ICD device and 
CardioMessenger II® 
Recruiting 
Effects of Remote Patient 
Monitoring on Heart Failure 
Management 
Heart 
Failure 
Heart failure remote 
patient monitoring 
system 
Recruiting 
Remote Follow-up of Patients 
Receiving Implantable 
Cardioverter Defibrillator for 
Prophylactic Therapy 
VT / VF ICD Completed 
TRIAGE-CRT Telemonitoring in 
Patients With CHF and Indication 
of CRT-D 
Heart 
Failure/ 
CRT 
KronosTM LV-T, 
LumaxTM HF-T 
Completed 
Follow-up of Patients With 
Implantable Cardioverter 
Defibrillators by Home Monitoring 
(ANVITE) 
VT / VF / 
Heart 
Failure 
ICD / CRT / Home 
MonitorTM 
Recruiting 
RAPID-RF: Remote Active 
Monitoring in Patients With Heart 
Failure 
Heart 
Failure / 
Atrial 
Fibrillation 
ICD / CRT Completed 
Supporting Care and 
Independence at Home 
Heart 
Failure 
Chronic heart failure 
monitoring system / 
Device: Lifestyle 
monitoring system 
Recruiting 
Home Monitoring in Cardiac 
Resynchronisation Therapy 
Heart 
Failure 
ICD / CRT  Completed 
Psychosomatic Effects of 
Implantable Cardioverter 
Defibrillator With Home 
Monitoring Function (QUANTUM)
Arrhythmia/ 
Quality of 
Life 
BIOTRONIK Lexos-
TTM ICD with home 
monitoring/ Device: 
Lumos-T® ICD with 
home monitoring 
Recruiting 
Evolution of Management 
Strategies of Heart Failure Patients 
With Implantable Defibrillators 
Heart 
Failure / 
SCD / ICD 
Medtronic CareLink® 
system 
Recruiting 
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Comparison Between Remote 
Patient Management and Standard 
Care in CRT-D and ICD-patients to 
Assess the Impact on Hospital 
Length of Stay Because of Heart 
Failure 
Heart 
Failure / VT 
/ VF 
CareAlert® / ICD / 
CRT 
Recruiting 
Evaluation of the " Tele-follow-up " 
for the Follow-up of Implantable 
Defibrillators 
Tele- follow-
up of CHF 
ICD / Telemedicine 
Active, not 
recruiting 
Actions elicited by In-hospital 
Follow-up of Cardiac Devices 
In-hospital 
follow-up of 
cardiac 
device 
ICD / Pacemaker Recruiting 
Table 6. Data from www.clinicaltrials.gov; accessed on July 22nd 2010 
ICD: Implantable Cardioverter Defibrillator 
VT: Ventricular Tachycardia 
VF: Ventricular Fibrillation 
SCD: Sudden Cardiac Death 
CRT: Cardiac Resynchronization therapy 
10. Remote programming 
Bidirectional telemetry uses encoded and encrypted radiofrequency signals which allows 
transmission of information from the pacemaker to the programmer and from the 
programmer to the pacemaker. In this way, the clinician can “talk” to the pacemaker, 
interrogate and get the necessary data from it and if needed, he/she can reprogram the 
device by sending signals to the pacemaker to optimize pacemaker function. Despite sound 
technology to program the pacemakers remotely, it is not yet implemented due to concerns 
over patient safety and privacy.  This concern is related to the limited ability to respond to 
potential changes in the patient’s condition as a result of the altered device parameters. As 
greater experience with remote monitoring is gained and as a secure support system for 
remote management of patients is developed, this technology will likely be implemented. 
Moreover, patient safety is a concern as, if some one may hack in to the secure system and 
change the settings / deactivate the devices. There have been no reports to date of hacking 
of implantable devices. 
11. Future directions 
In the future, the use of telemonitoring might dramatically reduce hospitalization rates of 
patient after pacemaker or ICD implantation. As mentioned in the table 6, there are many 
ongoing trials researching the benefit of earlier detection of a patient’s deterioration in 
clinical status (mainly heart failure) with the aid of Home monitoring. Clinical data such as 
trends in patients’ daily activity, in the mean heart rate and in the occurrence of arrhythmia, 
along with technical parameters will be correlated with major cardiovascular events – death 
and hospitalization.  
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12. Conclusions 
Rapidly evolving technological advances in wireless communication allow for the 
development of miniaturized devices and new techniques in telemonitoring. The safety of 
telemonitoring has been demonstrated in various trials.  The clinical use of tele monitoring 
is very promising based on the ongoing trials. This novel feature seems to be very important 
and might impact costs and therapeutic decisions. The relationship between patients and 
their physicians who perform pacemaker and ICD follow-up with telemonitoring should be 
more clearly defined so that patient – physician relationship is maintained. Remote 
programming of the pacemakers is a possibility in future. However patient safety due to 
hacking is a real concern.  
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